Both in Biotechnology
Candel Therapeutics vs Solid Biosciences
Over the past year CADL returned +76.4% and SLDB returned +48.0%; their daily moves had a correlation of 0.41.
CADL +76.4% SLDB +48.0%Growth of $1, one year, split-adjusted
| Metric | CADL | SLDB |
|---|---|---|
| Price | $9.05 | $6.52 |
| Market cap | $692.5M | $699.1M |
| Today | +2.61% | +3.82% |
| 1 month | −8.3% | −5.8% |
| 6 months | +18.6% | −9.4% |
| Year to date | +60.2% | +15.6% |
| 1 year | +73.4% | +25.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $153.7M | $377.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 68.4% |
| Short % of float | 21.5% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).